Education
About Us
Working with TipRanks
Follow Us
Ascletis Pharma, Inc. (HK:1672)
:1672
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
1672 Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Goldman Sachs
HK$1.99→HK$3.94
Hold
-39.85%
Downside
Reiterated
02/05/25
Ascletis Pharma Inc (1672:HK) (ASCLF) PT Raised to HK$3.94 at Goldman SachsGoldman Sachs analyst Ziyi Chen raised the price target on Ascletis Pharma Inc (1672:HK) (OTC: ASCLF) to HK$3.94 (from HK$1.99) while maintaining a Neutral rating.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Goldman Sachs
HK$1.99→HK$3.94
Hold
-39.85%
Downside
Reiterated
02/05/25
Ascletis Pharma Inc (1672:HK) (ASCLF) PT Raised to HK$3.94 at Goldman SachsGoldman Sachs analyst Ziyi Chen raised the price target on Ascletis Pharma Inc (1672:HK) (OTC: ASCLF) to HK$3.94 (from HK$1.99) while maintaining a Neutral rating.
Best Analysts Covering Ascletis Pharma, Inc.
Which Analyst Should I Follow If I Want to Buy HK:1672 and Sell After:
1 Month
xxx
Success Rate
2/4 ratings generated profit
Average Return
-4.00%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -4.00% per trade.
3 Months
xxx
Success Rate
0/4 ratings generated profit
Average Return
-20.52%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -20.52% per trade.
1 Year
2 Years
xxx
Success Rate
4/4 ratings generated profit
Average Return
+232.80%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +232.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
1672 Analyst Recommendation Trends
Rating
Aug 23
Jan 24
Mar 24
Apr 24
Feb 25
Strong Buy
1
2
3
3
2
Buy
0
0
0
0
0
Hold
0
1
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
3
4
4
3
Each month's total comprises the sum of three months' worth of ratings.
1672 Stock Forecast FAQ
What is HK:1672’s average 12-month price target, according to analysts?
Based on analyst ratings, Ascletis Pharma, Inc.’s 12-month average price target is 3.94.
What is HK:1672’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:1672, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Ascletis Pharma, Inc. a Buy, Sell or Hold?
Ascletis Pharma, Inc. has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Ascletis Pharma, Inc.’s share price target?
The average share price target for Ascletis Pharma, Inc. is 3.94. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$3.94 ,and the lowest forecast is HK$3.94. The average share price target represents -39.85% Decrease from the current price of HK$6.55.
The highest analyst share price target is HK$3.94 ,and the lowest forecast is HK$3.94. The average share price target represents -39.85% Decrease from the current price of HK$6.55.
What do analysts say about Ascletis Pharma, Inc.?
Ascletis Pharma, Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Ascletis Pharma, Inc.?
To buy shares of HK:1672, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.